These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15193294)

  • 41. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
    Bishop C; Daut GS; Walker PD
    Neuropharmacology; 2005 Sep; 49(3):350-8. PubMed ID: 15993442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphodiesterase 10A inhibitor, MP-10 (PF-2545920), produces greater induction of c-Fos in dopamine D2 neurons than in D1 neurons in the neostriatum.
    Wilson JM; Ogden AM; Loomis S; Gilmour G; Baucum AJ; Belecky-Adams TL; Merchant KM
    Neuropharmacology; 2015 Dec; 99():379-86. PubMed ID: 26256420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C; Abraini JH; David HN
    Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors.
    Houchi H; Babovic D; Pierrefiche O; Ledent C; Daoust M; Naassila M
    Neuropsychopharmacology; 2005 Feb; 30(2):339-49. PubMed ID: 15383833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function.
    Fernandez-Espejo E; Caraballo I; Rodriguez de Fonseca F; Ferrer B; El Banoua F; Flores JA; Galan-Rodriguez B
    Neuropsychopharmacology; 2004 Jun; 29(6):1134-42. PubMed ID: 15010694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
    Glass M; Dragunow M; Faull RL
    Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
    Berridge KC; Aldridge JW
    Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism.
    Fernandez-Espejo E; Caraballo I; de Fonseca FR; El Banoua F; Ferrer B; Flores JA; Galan-Rodriguez B
    Neurobiol Dis; 2005 Apr; 18(3):591-601. PubMed ID: 15755685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys.
    Madsen MV; Peacock LP; Werge T; Andersen MB; Andreasen JT
    Neuropharmacology; 2011; 60(2-3):418-22. PubMed ID: 21029743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats.
    Chaves-Kirsten GP; Mazucanti CH; Real CC; Souza BM; Britto LR; Torrão AS
    PLoS One; 2013; 8(10):e76874. PubMed ID: 24116178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat.
    Galvan A; Floran B; Erlij D; Aceves J
    J Neural Transm (Vienna); 2001; 108(2):153-66. PubMed ID: 11314770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophysiological and behavioral output of the rat basal ganglia after intrastriatal infusion of d-amphetamine: lack of support for the basal ganglia model.
    Waszczak BL; Martin L; Boucher N; Zahr N; Sikes RW; Stellar JR
    Brain Res; 2001 Nov; 920(1-2):170-82. PubMed ID: 11716823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The indirect basal ganglia pathway in dopamine D(2) receptor-deficient mice.
    Murer MG; Dziewczapolski G; Salin P; Vila M; Tseng KY; Ruberg M; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Hirsch E; Raisman-Vozari R; Gershanik O
    Neuroscience; 2000; 99(4):643-50. PubMed ID: 10974427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015.
    Farkas S; Nagy K; Jia Z; Harkany T; Palkovits M; Donohou SR; Pike VW; Halldin C; Máthé D; Csiba L; Gulyás B
    Brain Res Bull; 2012 Apr; 87(6):504-10. PubMed ID: 22421165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [
    Mann T; Kurth J; Hawlitschka A; Stenzel J; Lindner T; Polei S; Hohn A; Krause BJ; Wree A
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29509680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Power fluctuations in beta and gamma frequencies in rat globus pallidus: association with specific phases of slow oscillations and differential modulation by dopamine D1 and D2 receptors.
    Dejean C; Arbuthnott G; Wickens JR; Le Moine C; Boraud T; Hyland BI
    J Neurosci; 2011 Apr; 31(16):6098-107. PubMed ID: 21508235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys.
    Madsen MV; Peacock L; Werge T; Andersen MB
    J Psychopharmacol; 2006 Sep; 20(5):622-8. PubMed ID: 16533866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors.
    Ramiro-Fuentes S; Fernandez-Espejo E
    Psychopharmacology (Berl); 2011 Apr; 214(4):949-59. PubMed ID: 21128069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats.
    Need AB; Davis RJ; Alexander-Chacko JT; Eastwood B; Chernet E; Phebus LA; Sindelar DK; Nomikos GG
    Psychopharmacology (Berl); 2006 Jan; 184(1):26-35. PubMed ID: 16328376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.